MIB2 is a pro-survival E3 ubiquitin ligase that cooperates with the IAPs and TAK1 to limit the pro-apoptotic activities of RIPK1, thereby reducing TNF-mediated cancer cell death. This evidence concerns the gene RIPK1 and cancer.